Last reviewed · How we verify
NCT04755569
Optimizer System With ODOCOR II CCM™ Leads
trial testing ODOCOR II CCM LEADS in Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead in 200 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Impulse Dynamics |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 March 2021 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2025 |
| Sites | 40 locations across Italy, Germany, Spain |
Drugs / interventions tested
- ODOCOR II CCM LEADS
Conditions studied
- Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead — all drugs for Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead →
Sponsor
Impulse Dynamics — full company profile →
Who can join
18 and older, any sex, with Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the ODOCOR II CCM lead study is to evaluate the safety and useability of the ODOCOR II intra-cardiac lead specifically intended to deliver CCM as an accessory lead to the Optimizer IPG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04755569
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Impulse Dynamics trials
Trials by the same sponsor.
- NCT07112924 — CCM OPEN HF Registry · recruiting
- NCT05064709 — Assessment of CCM in HF With Higher Ejection Fraction · NA · recruiting
- NCT03240237 — CCM in Heart Failure With Preserved Ejection Fraction · NA · completed
- NCT03339310 — Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System · NA · completed
- NCT03102437 — Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04755569 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Impulse Dynamics
- Last refreshed: 2 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04755569.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing